Virginie Adam

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Positive Breast Cancer

Top Venues

Future oncology (London, England)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Veronique Debien, Virginie Adam, Elisabeth Coart, Elisa Agostinetto, Theodora Goulioti, Chiara Molinelli, Amal Arahmani, Francesco Ravera, Martine Piccart
DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer. Future oncology (London, England) (2023)
José Alejandro Pérez-Fidalgo, Carmen Criscitiello, Eva Carrasco, Meredith M Regan, Angelo Di Leo, Karin Ribi, Virginie Adam, Philippe L Bedard
A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ PIK3CA -mutated breast cancer. Future oncology (London, England) 18 (19) (2022)
Nicholas C Turner, Judith Balmaña, Coralie Poncet, Theodora Goulioti, Konstantinos Tryfonidis, Aafke H Honkoop, Gabriele Zoppoli, Evangelia D Razis, Oskar T Johannsson, Marco Colleoni, Andrew N J Tutt, William Audeh, Michail Ignatiadis, Audrey Mailliez, Olivier Trédan, Antonino Musolino, Peter Vuylsteke, Maria Jose Juan-Fita, Iain R J Macpherson, Bella Kaufman, Luis Manso, Lori J Goldstein, Susan L Ellard, István Láng, Kai Yu Jen, Virginie Adam, Saskia Litière, John Erban, David A Cameron, null null
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)